rilzabrutinib
General
Pronunciation:
ril-za-broo-ti-nib
Trade Name(s)
- Wayrilz
Ther. Class.
none assigned
Pharm. Class.
kinase inhibitors
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Rilzabrutinib." Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. Nursing Central, nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580140/5/rilzabrutinib.
Vallerand AHA, Sanoski CAC. Rilzabrutinib. Davis's Drug Guide. F.A. Davis Company; 2026. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580140/5/rilzabrutinib. Accessed June 30, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Rilzabrutinib. In Davis's Drug Guide (20th ed.). F.A. Davis Company. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580140/5/rilzabrutinib
Vallerand AHA, Sanoski CAC. Rilzabrutinib [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 June 30]. Available from: https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580140/5/rilzabrutinib.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - rilzabrutinib
ID - 3580140
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580140/5/rilzabrutinib
PB - F.A. Davis Company
ET - 20
DB - Nursing Central
DP - Unbound Medicine
ER -

Davis's Drug Guide

